开放式参考框架
生物
打开阅读框
免疫原性
表位
蛋白质组
人类白细胞抗原
病毒学
人类蛋白质组计划
计算生物学
遗传学
抗原
蛋白质组学
肽序列
基因
作者
Shira Weingarten-Gabbay,Susan Klaeger,Siranush Sarkizova,Leah R. Pearlman,Da‐Yuan Chen,Kathleen Gallagher,Matthew R. Bauer,Hannah B. Taylor,Walter Dunn,Christina Tarr,John Sidney,Suzanna Rachimi,Hasahn L. Conway,Katelin Katsis,Yuntong Wang,Del Leistritz-Edwards,Melissa Durkin,Christopher H. Tomkins-Tinch,Yaara Finkel,Aharon Nachshon
出处
期刊:Cell
[Cell Press]
日期:2021-06-03
卷期号:184 (15): 3962-3980.e17
被引量:131
标识
DOI:10.1016/j.cell.2021.05.046
摘要
T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and nucleocapsid not captured by current vaccines. Some peptides from out-of-frame ORFs elicited T cell responses in a humanized mouse model and individuals with COVID-19 that exceeded responses to canonical peptides, including some of the strongest epitopes reported to date. Whole-proteome analysis of infected cells revealed that early expressed viral proteins contribute more to HLA-I presentation and immunogenicity. These biological insights, as well as the discovery of out-of-frame ORF epitopes, will facilitate selection of peptides for immune monitoring and vaccine development.
科研通智能强力驱动
Strongly Powered by AbleSci AI